GlassScriptPhysician profile
Barbara L Fuller
NPI 1972545804
$2,043.49
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,461 · 2020: $509 · 2021: $40.13 · 2023: $32.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $255.96 | 2019-2020 | |
| Amgen INC. | $218.93 | 2019-2021 | |
| Pfizer INC. | $175.57 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $154.53 | 2019-2020 | |
| Abbvie INC. | $119.22 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $109.50 | 2019-2020 | |
| Tesaro, INC. | $98.24 | 2019 | |
| Lilly USA, LLC | $95.68 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $92.47 | 2019 | |
| Incyte Corporation | $89.82 | 2019-2020 | |
| Genentech USA, INC. | $87.46 | 2019 | |
| Janssen Biotech, INC. | $84.52 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $79.73 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $70.44 | 2019-2020 | |
| Genzyme Corporation | $56.52 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $47.70 | 2019-2020 | |
| Astellas Pharma US INC | $45.76 | 2019 | |
| Karyopharm Therapeutics INC. | $45.20 | 2020 | |
| Medtronic USA, INC. | $41.68 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.90 | 2020 | |
| Beigene USA, INC. | $17.25 | 2020 | |
| Alexion Pharmaceuticals, INC. | $14.44 | 2019 | |
| Acrotech Biopharma INC. | $11.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Fuller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.